Works matching IS 2160763X AND DT 2024 AND VI 13 AND IP 5

Results: 13

Comparative Bioequivalence and Food Effect of Two Formulations of 30‐mg Nifedipine Controlled‐Release Tablets in Healthy Chinese Adults.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 499, doi. 10.1002/cpdd.1396

By:

Zhang, Huizi;
Wang, Siyang;
Wang, Hongxia;
Zhi, Tingting;
Ren, Jian;
Wang, Yanhui;
Yao, Zhiqing;
Zhang, Pan;
Ye, Naobei;
Zhang, Ruiqin

Publication type:

Article

Pharmacokinetic Evaluation of the CYP3A4 and CYP2C9 Drug‐Drug Interaction of Avacopan in 2 Open‐Label Studies in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 517, doi. 10.1002/cpdd.1389

By:

Miao, Shichang;
Bekker, Pirow;
Armas, Danielle;
Lor, Mary;
Han, Yanyan;
Webster, Kenneth;
Trivedi, Ashit

Publication type:

Article

Safety, Pharmacokinetics, and Pharmacodynamics of Etrasimod: Single and Multiple Ascending Dose Studies in Healthy Adults.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 534, doi. 10.1002/cpdd.1379

By:

Lee, Caroline A.;
Schreiber, Stefan;
Bressler, Brian;
Adams, John W.;
Oh, Dooman Alexander;
Tang, Yong Q.;
Zhang, Jinkun;
Komori, Heather Kiyomi;
Grundy, John S.

Publication type:

Article

Two‐Part Phase 1 Study to Evaluate the Taste Profile of Novel Belumosudil Oral Suspensions and Assess the Relative Bioavailability and Food Effect of the Selected Belumosudil Oral Suspension Compared With Oral Tablet Reference in Healthy Male Participants

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 491, doi. 10.1002/cpdd.1378

By:

Schueller, Olivier;
Regev, Galit;
Singh, Nand;
Willson, Ashley;
Beville, Mark;
Kanji, Nazim;
Lohmer, Lauren;
Patel, Jeegar

Publication type:

Article

Cedirogant Population Pharmacokinetics and Pharmacodynamic Analyses of Interleukin‐17A Inhibition in Two Phase 1 Studies in Healthy Participants and Participants with Moderate to Severe Psoriasis.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 474, doi. 10.1002/cpdd.1377

By:

Maier, Corinna S.;
Eckert, Doerthe;
Laroux, F. Stephen;
Hew, Kinjal M.;
Suleiman, Ahmed A.;
Liu, Wei;
Mohamed, Mohamed‐Eslam F.

Publication type:

Article

Concentration‐QTcF Modeling of Icenticaftor from a Randomized, Placebo‐ and Positive‐Controlled Thorough QT Study in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 572, doi. 10.1002/cpdd.1374

By:

Iyer, Ganesh R.;
Darpo, Borje;
Xue, Hongqi;
Lecot, Jean;
Zack, Julia;
Bebrevska, Lidiya;
Weis, Wendy;
Jones, Ieuan;
Drollmann, Anton

Publication type:

Article

Relative Oral Bioavailability and Food Effects of Two Sepiapterin Formulations in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 506, doi. 10.1002/cpdd.1363

By:

Gao, Lan;
Kaushik, Diksha;
Xia, Yi;
Ingalls, Kimberly;
Milner, Sarah;
Smith, Neil;
Kong, Ronald

Publication type:

Article

Population Pharmacokinetics of the Novel Adenosine A<sub>2A</sub> Antagonist/Inverse Agonist KW‐6356 and Its Active Metabolite Following Single and Multiple Oral Administration in Healthy Individuals and Patients with Parkinson's Disease.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 549, doi. 10.1002/cpdd.1359

By:

Tayama, Tomonori;
Okada, Hiroki;
Ogawa, Kotoko;
Marsteller, Douglas;
Maeda, Hiroshi;
Hruska, Matthew W.;
Kagawa, Yoshiyuki

Publication type:

Article

Population Pharmacokinetic Modeling and Simulation of Pudexacianinium (ASP5354) for Dose Setting of a Phase 2 First‐in‐Patient Study: A Novel Imaging Agent for Intraoperative Ureter Visualization during Abdominopelvic Surgery.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 454, doi. 10.1002/cpdd.1354

By:

Saito, Masako;
Kojima, Tomoki;
Komatsu, Kanji;
Takusagawa, Shin

Publication type:

Article

Safety and Pharmacokinetics of Quizartinib Combination Therapy With Standard Induction and Consolidation Chemotherapy in Patients With Newly Diagnosed Acute Myeloid Leukemia: Results from Two Phase 1 Trials in Japan and China.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 560, doi. 10.1002/cpdd.1353

By:

Qi, Junyuan;
Choi, Ilseung;
Ota, Shuichi;
Ichikawa, Satoshi;
Fujishima, Naohito;
Iida, Hiroatsu;
Sugiura, Isamu;
Sugiura, Koichi;
Murata, Yasuharu;
Inoue, Hiroyuki;
Ohwada, Shoichi;
Wang, Jianxiang

Publication type:

Article

A Drug‐Drug Interaction Study to Evaluate the Impact of Rimegepant on OCT2‐ and MATE1‐Mediated Transport of Metformin in Healthy Participants.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 465, doi. 10.1002/cpdd.1352

By:

Bhardwaj, Rajinder;
Morris, Beth;
Matschke, Kyle;
Bertz, Richard;
Croop, Robert;
Liu, Jing

Publication type:

Article

Bioequivalence Study of Epalrestat for Healthy Chinese Subjects.

Published in:

Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 485, doi. 10.1002/cpdd.1347

By:

Yang, Dandan;
Wang, Xiaodan;
Duan, Yi;
Xu, Yichao;
Ruan, Zourong;
Jiang, Bo;
Lou, Honggang;
Chen, Jinliang

Publication type:

Article

Issue Information.

Published in:: Clinical Pharmacology in Drug Development, 2024, v. 13, n. 5, p. 449, doi. 10.1002/cpdd.1118
Publication type:: Article